Loop-mediated Isothermal Amplification - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The loop-mediated isothermal amplification market size is expected to increase from USD 0.76 billion in 2025 to USD 0.86 billion in 2026 and reach USD 1.52 billion by 2031, growing at a CAGR of 12.11% over 2026-2031. This report is segmented by Product (Instruments and Reagents & Consumables), Technology (Microfluidic, Infrared Optical, and More), Application (Infectious-Disease Diagnostics, and More), End User (Hospitals and Clinics, Diagnostic Laboratories, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). Forecasts are in Value (USD).

Global Loop-mediated Isothermal Amplification Market Trends and Insights

Faster Results Than Conventional PCR

LAMP can return positive results within 15 to 30 minutes at a fixed 60 to 65°C. Conventional qPCR can require 60 to 90 minutes because it uses repeated thermal cycling steps. Thermo Fisher described a lyo-ready Bst polymerase that supported detection in under 10 minutes under its stated conditions. Faster pathogen identification can shorten the period of empirical antibiotic prescribing in hospitals. This makes the loop-mediated isothermal amplification market relevant to antimicrobial stewardship programs and physician office testing. The 30 FDA-authorized microbial LAMP tests cataloged in 2025 also provide a regulatory precedent for later assays.

Decentralized Infectious-Disease Testing

Many health facilities lack the infrastructure needed to operate conventional PCR systems. LAMP platforms can be used where laboratory space, trained operators, or stable grid power are limited. Eiken Chemical presented a solar-powered, battery-operated Malaria-LAMP instrument that produces results in 1.5 hours without grid electricity. This configuration supports use at community health posts in high-burden infectious disease settings. Distributed testing infrastructure can also support preparedness programs that need testing closer to affected populations. These operating conditions broaden the addressable settings for the loop-mediated isothermal amplification market.

PCR Switching Costs and Established Laboratory Workflows

High-volume clinical laboratories have established PCR workflows, validation procedures, and operator training. Moving to LAMP can require new primer libraries and revised quality documentation. Laboratories may also need to validate results against their existing PCR reference methods. Large qPCR platforms often carry multiyear service agreements that discourage mid-cycle replacement. The barrier is strongest in centralized laboratories, where LAMP has a smaller operational advantage. This can slow uptake in the loop-mediated isothermal amplification market across North America and Europe.

Other drivers and restraints analyzed in the detailed report include:

• Simplified Workflow and Low Infrastructure Requirements
• Expansion of Food-Safety and Environmental Testing
• Reimbursement and Evidence Gaps for Decentralized Testing

Segment Analysis

Reagents and consumables held 59.65% of product revenue in 2025. This share reflects the recurring purchase pattern that follows instrument placement. Each installed instrument can generate repeat demand for enzymes, master mixes, cartridges, and other assay materials. This makes reagent supply relationships important for suppliers serving hospitals and diagnostic laboratories. Meridian Bioscience offered lyo-ready and air-dryable LAMP master mixes that combine polymerase, buffer, dNTPs, and compatible excipients. Such materials can support ambient-stable workflows and reduce cold-chain requirements. Thermo Fisher’s glycerol-free lyo-ready Bst polymerase was positioned for microfluidic-compatible assays. These features support continued reagent demand within the loop-mediated isothermal amplification market. The product mix gives established reagent suppliers a durable position after instrument sales are completed.

Instruments are projected to grow at a CAGR of 14.65% from 2026 to 2031. The loop-mediated isothermal amplification market size for instruments is supported by compact fluorescence optics, infrared heating, and connected readouts. Manufacturers are integrating Bluetooth and Wi-Fi functions into smaller devices for point-of-care use. Compact systems can reduce physical space requirements while preserving analytical capability. ISO 13485 and the EU In Vitro Diagnostic Regulation create meaningful entry requirements for device suppliers. These requirements favor companies that can support validation, documentation, and quality systems. Laboratories also seek to expand molecular menus without the higher initial commitment associated with qPCR platforms. Growth in instruments therefore complements rather than displaces recurring consumables demand. The two product categories create separate routes to value in the loop-mediated isothermal amplification market.

Microfluidic technology held 63.65% of technology revenue in 2025. Its share reflects the ability to combine sample loading, amplification, and signal detection in a sealed cartridge. A closed cartridge can reduce contamination risk and lower the amount of operator handling. These benefits are important for clinical laboratories assessing decentralized testing methods. A 2025 portable device combined RT-qPCR and RT-LAMP with passive flow control in a compact format. The reported workflow reduced total assay time to 42 minutes and maintained equivalent quantitative accuracy. Microfluidics also supports a smaller instrument footprint than conventional qPCR systems. This technology base supports the largest portion of the loop-mediated isothermal amplification market. It remains important for sample-to-answer workflows that must be simple and contained.

Advanced infrared optical technology is projected to grow at a CAGR of 14.76% from 2026 to 2031. Noncontact infrared heating can avoid precision-machined heating blocks and reduce power use. It can also control temperature in sealed reaction chambers without physical contact. This design can reduce aerosol contamination risk in decentralized settings. A 2026 chip combined aerosol sampling with LAMP-CRISPR infrared detection for airborne virus surveillance in 85 minutes. The example linked infrared-enabled testing with biosecurity and environmental monitoring. Smartphone-readable fluorescence channels may widen access where conventional fluorescence readers are unavailable. These attributes support future technology choices in the loop-mediated isothermal amplification market. Modern microsystem technology also remains relevant for paper-based and printed circuit board formats that seek lower fabrication costs.

Complete Report Scope:

• By Product
  • Instruments
  • Reagents & Consumables
• By Technology
  • Microfluidic Technology
  • Advanced Infrared Optical Technology
  • Modern Microsystem Technology
  • Other Technologies
• By Application
  • Infectious-Disease Diagnostics
  • Food-Safety Testing
  • Veterinary Diagnostics
  • Oncology and Genetic Testing
• By End User
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Point-of-Care and Decentralized Clinics
  • Research and Academic Institutes
  • Other End Users
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 44.28% of global revenue in 2025, the largest regional share. The region has a dense network of CLIA-certified laboratories and an established molecular diagnostics infrastructure. The supplied draft identified CPT code 87426 as a clear public-payer signal for qualifying infectious-agent testing. The United States anchors regional demand, while Canada and Mexico are integrating point-of-care testing for tuberculosis and respiratory surveillance. The July 2026 Pro-AMP launch described in the supplied draft indicated continued interest in physician office laboratory settings. Europe remained the second-largest region, led by Germany, the United Kingdom, and France. The EU IVDR cycle has encouraged portfolio updates and compliance-led market access. bioMérieux received IVDR CE marking for BIOFIRE SPOTFIRE respiratory panels in March 2026. These dynamics sustain established demand in the loop-mediated isothermal amplification market.

Asia-Pacific is projected to grow at a CAGR of 13.54% from 2026 to 2031. China’s IVD manufacturing capacity, India's decentralized testing programs, and Japan’s approval processes shape regional demand. Eiken Chemical is the original LAMP patent holder and demonstrated Malaria-LAMP implementation in the region during June 2026. The platform’s solar-powered design supports locations without reliable grid electricity. The supplied draft also described Molbio Diagnostics’ plans to expand its disease panel across infectious and veterinary applications. India’s CDSCO rules and China’s Class III IVD pathway influence product entry and validation requirements. These regulatory conditions can support wider use of compliant devices and assays. Asia-Pacific, therefore, provides the strongest regional growth outlook for the loop-mediated isothermal amplification market.

The Middle East, Africa, and South America are smaller regional markets with distinct operational needs. Cold-chain-free reagents and solar-compatible instruments can be suitable for African testing settings with infrastructure constraints. Eiken Chemical’s TB-LAMP received WHO support in the supplied draft, providing a relevant validation pathway for high-burden infectious disease testing. GCC countries are investing in domestic diagnostics capacity, creating opportunities for suppliers with localization capabilities. Brazil, Argentina, and Mexico provide key South American demand centers as district-level laboratory capacity expands. Regional surveillance programs can increase demand for molecular testing closer to communities. These factors create longer-term openings for the loop-mediated isothermal amplification market.

List of Companies Covered in this Report:

• Abbott Laboratories
• Atila BioSystems, Inc.
• Beckton Dickinson
• Canon
• DiaSorin
• Fujirebio Holdings, Inc.
• Genomtec S.A.
• HiberGene Diagnostics Limited
• IQGEN N.V.
• Lucigen
• Mast Group Ltd.
• Meridian Bioscience, Inc.
• NIPPON GENE CO., LTD.
• New England Biolabs
• OptiGene
• QuidelOrtho
• Sysmex
• Thermo Fisher Scientific
• Ustar Biotechnologies (Hangzhou) Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support